Skip to content

Study · Non-randomized trial · n = 30 · 1984

6 results

[Thymalin as a modulator of immunogenesis and hemostasis].

Kuznik BI, Budazhabon GB, Budazhabon NG, Morozov VG, Pinelis IS

Farmakologiia i toksikologiia1 Jan 1984

PMID6546722 (opens in a new tab)PepBankPUB-06546722
Publisher pageAsk about this study
Jump to 6 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

6 results from studies that gave the peptide. 6 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with periodontosis, thymaline improved general health status.

    In plain wordsIn patients with periodontosis, thymaline improved general health.

    Peptide
    Thymalin
    Outcome
    IncreaseGeneral health status
    Study

    n = 30

    Outcome group
    Overall treatment effect · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Studies made in 30 patients with periodontosis have shown that thymaline improves the general health status of patients
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with periodontosis, thymaline promoted normalization of cellular immunity.

    In plain wordsIn patients with periodontosis, thymaline helped cellular immunity return to normal.

    Peptide
    Thymalin
    Outcome
    Direction not reportedCellular immunity
    Study

    n = 30

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Studies made in 30 patients with periodontosis have shown that thymaline improves the general health status of patients, thereby promoting the normalization of cellular and, to a lesser degree, humoral immunity.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with periodontosis, thymaline promoted normalization of humoral immunity to a lesser degree than cellular immunity.

    In plain wordsIn patients with periodontosis, thymaline helped antibody immunity return to normal, less strongly than cellular immunity.

    Peptide
    Thymalin
    Outcome
    Direction not reportedHumoral immunity
    Study

    n = 30

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Studies made in 30 patients with periodontosis have shown that thymaline improves the general health status of patients, thereby promoting the normalization of cellular and, to a lesser degree, humoral immunity.
  4. 04HumanNon-randomized trialEfficacy outcome

    In patients with periodontosis, thymaline normalized blood coagulation.

    In plain wordsIn patients with periodontosis, thymaline returned blood clotting to normal.

    Peptide
    Thymalin
    Outcome
    Direction not reportedBlood coagulation
    Study

    n = 30

    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    At the same time the drug normalizes blood coagulation, the total and Hageman factor-dependent fibrinolysis.
  5. 05HumanNon-randomized trialEfficacy outcome

    In patients with periodontosis, thymaline normalized total fibrinolysis.

    In plain wordsIn patients with periodontosis, thymaline returned total blood clot breakdown to normal.

    Peptide
    Thymalin
    Outcome
    Direction not reportedTotal fibrinolysis
    Study

    n = 30

    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    At the same time the drug normalizes blood coagulation, the total and Hageman factor-dependent fibrinolysis.
  6. 06HumanNon-randomized trialEfficacy outcome

    In patients with periodontosis, thymaline normalized Hageman factor-dependent fibrinolysis.

    In plain wordsIn patients with periodontosis, thymaline returned Hageman factor-dependent blood clot breakdown to normal.

    Peptide
    Thymalin
    Outcome
    Direction not reportedHageman factor-dependent fibrinolysis
    Study

    n = 30

    Outcome group
    Bleeding and clotting · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    At the same time the drug normalizes blood coagulation, the total and Hageman factor-dependent fibrinolysis.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.